Prostaglandin D(2) inhibits C2C12 myogenesis.

Research output: Contribution to journalArticle

15 Citations (Scopus)


Muscle repair following injury is preceded by a rapid inflammatory response with myoblasts being exposed to high levels of prostaglandin D(2) (PGD(2)) from invading leukocytes. We demonstrate that PGD(2) strongly inhibits C2C12 myogenesis as measured by cell fusion, creatine kinase activity and MyoD, myogenin and alpha-actin expression. Inhibition of myogenesis required micromolar PGD(2) concentrations and was independent of the known PGD(2) receptors DP1 and DP2. Unlike its cyclopentenone derivative 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)), PGD(2) did not generate toxic mitochondrial superoxide indicating that the inhibition of myogenesis is not mediated by generation of high concentrations of PGD(2)-derived 15d-PGJ(2). Thus our observations provide evidence for a novel PGD(2) signalling mechanism during muscle repair exclusively mediated by high inflammatory associated PGD(2) concentrations. These findings indicate a complex interplay between myoblasts and inflammatory cells during the repair process and have implications for the use of non-steroidal anti-inflammatory drugs in the treatment of muscle injuries.
Original languageEnglish
JournalMolecular and Cellular Endocrinology
Publication statusPublished - 28 Jan 2010


  • Healing
  • Myogenesis
  • COX-2
  • Prostaglandin


Dive into the research topics of 'Prostaglandin D(2) inhibits C2C12 myogenesis.'. Together they form a unique fingerprint.

Cite this